<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cerebral small vessel disease (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SVD</z:e>) is an important cause of <z:hpo ids='HP_0001297'>stroke</z:hpo>, <z:hpo ids='HP_0001268'>cognitive decline</z:hpo> and vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (VaD) </plain></SENT>
<SENT sid="1" pm="."><plain>It is associated with <z:hpo ids='HP_0007204'>diffuse white matter abnormalities</z:hpo> and small deep cerebral ischemic <z:mpath ids='MPATH_124'>infarcts</z:mpath> </plain></SENT>
<SENT sid="2" pm="."><plain>The molecular mechanisms involved in the development and progression of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SVD</z:e> are unclear </plain></SENT>
<SENT sid="3" pm="."><plain>As <z:hpo ids='HP_0000822'>hypertension</z:hpo> is a major risk factor for developing <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SVD</z:e>, Spontaneously Hypertensive Rats (SHR) are considered an appropriate experimental model for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SVD</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Prior work suggested an imbalance between the number of blood microvessels and astrocytes at the level of the neurovascular unit in 2-month-old SHR, leading to neuronal <z:mp ids='MP_0005039'>hypoxia</z:mp> in the brain of 9-month-old animals </plain></SENT>
<SENT sid="5" pm="."><plain>To identify genes and pathways involved in the development of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SVD</z:e>, we compared the gene expression profile in the cortex of 2 and 9-month-old of SHR with age-matched normotensive Wistar Kyoto (WKY) rats using microarray-based technology </plain></SENT>
<SENT sid="6" pm="."><plain>The results revealed significant differences in expression of genes involved in energy and <z:chebi fb="23" ids="18059">lipid</z:chebi> metabolisms, <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> functions, <z:mp ids='MP_0003674'>oxidative stress</z:mp> and ischemic responses between both groups </plain></SENT>
<SENT sid="7" pm="."><plain>These results strongly suggest that SHR suffer from <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mp ids='MP_0005039'>hypoxia</z:mp>, and therefore are unable to tolerate <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-like conditions, and are more vulnerable to high-energy needs than WKY </plain></SENT>
<SENT sid="8" pm="."><plain>This molecular analysis gives new insights about pathways accounting for the development of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SVD</z:e> </plain></SENT>
</text></document>